Literature DB >> 16788968

Effects of bone protein extract on human mesenchymal stem cells proliferation and differentiation.

Charlotte Woo1, Haisheng Li, Anette Baatrup, Andrea Krause, Moustapha Kassem, Cody Bunger, Martin Lind.   

Abstract

Since its osteoinductive capacity has been established, demineralized bone matrix is considered a suitable alternative to bone autograft in the healing of osseous defects. The mechanisms of bone formation induction are still not fully understood. In this study we assessed the effects of a dispersion of bovine bone extract COLLOSS (BPE) with regard to proliferation and differentiation of a human mesenchymal stem cell line overexpressing human telomerase reverse transcriptase (hMSC-TERT). Proliferation rate was determined by (3)H-thymidine incorporation. The differentiation of hMSC-TERT cells to osteoblastic cells was assessed by means of measuring alkaline phosphatase activity and collagen synthesis in vitro. Both undifferentiated and osteoblast-differentiated hMSC-TERT cells were investigated for response to BPE. The metabolic responses to BPE were compared to unstimulated cells and cells stimulated with bovine collagen (COL). Undifferentiated hMSC-TERT cells responded to BPE with increased proliferation and decreased alkaline phosphatase activity. Osteoblastic differentiated hMSC-TERT cells had a diminished proliferative response and an increased alkaline phosphatase activity and collagen synthesis. Our study demonstrated significant metabolic effects of BPE on hMSC-TERT cells, which were highly dependant on the differentiated state of the cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16788968     DOI: 10.1002/jbm.a.30892

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  1 in total

1.  The effect of adding an equine bone matrix protein lyophilisate on fixation and osseointegration of HA-coated Ti implants.

Authors:  Jorgen Baas; Thomas Jakobsen; Brian Elmengaard; Joan E Bechtold; Kjeld Soballe
Journal:  J Biomed Mater Res A       Date:  2011-10-23       Impact factor: 4.396

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.